Global DTIs for Injection Supply, Demand and Key Producers, 2024-2030

Description

Direct Thrombin Inhibitors (DTIs) for injection are a category of anticoagulant medications that directly inhibit thrombin, a key enzyme in the blood clotting process. By blocking thrombin's ability to convert fibrinogen into fibrin, DTIs prevent the formation of blood clots. Administered via intravenous or subcutaneous injection, these drugs are used primarily in hospital settings for conditions requiring acute anticoagulation, such as during surgeries or in patients with deep vein thrombosis or pulmonary embolism.

The global DTIs for Injection market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

The market for Direct Thrombin Inhibitors (DTIs) for injection has evolved significantly in recent years, driven by their advantages in acute anticoagulation settings. Initially, DTIs were introduced to address limitations of traditional anticoagulants like heparin, offering benefits such as direct inhibition of thrombin, which simplifies the management of anticoagulation. The increasing prevalence of conditions such as deep vein thrombosis (DVT) and pulmonary embolism, alongside advancements in surgical techniques, has spurred demand for these specialized medications. Their use in high-risk settings, including complex surgeries and critical care, has solidified their role in acute medical management.

Competition in the DTI market has intensified with the introduction of several new products, each striving to offer improved safety profiles, efficacy, and convenience. For example, bivalirudin and argatroban have emerged as leading options, with distinct advantages in specific clinical scenarios. This competitive landscape has driven innovation and refinement in DTI formulations, including enhancements in delivery methods and dosing regimens. Despite this, the market remains relatively niche compared to broader anticoagulant categories, primarily due to the specific clinical indications and higher costs associated with injectable DTIs.

Looking ahead, the DTI market is poised for steady growth, driven by ongoing advancements in medical technology and increasing adoption in surgical and intensive care settings. Continued research and development efforts are expected to focus on improving the efficacy, safety, and patient outcomes associated with these drugs. However, challenges such as high costs and the emergence of alternative anticoagulants may impact market dynamics. Overall, the market for DTIs for injection remains dynamic, with strong prospects tied to their critical role in managing acute thrombotic events.

This report studies the global DTIs for Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for DTIs for Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of DTIs for Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global DTIs for Injection total production and demand, 2019-2030, (K Units)
Global DTIs for Injection total production value, 2019-2030, (USD Million)
Global DTIs for Injection production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global DTIs for Injection consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: DTIs for Injection domestic production, consumption, key domestic manufacturers and share
Global DTIs for Injection production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global DTIs for Injection production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global DTIs for Injection production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global DTIs for Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mitsubishi Tanabe Pharma, Pfizer, Sandoz, The Medicines Company, Accord Healthcare, Apotex, Aurobindo Pharma, GlaxoSmithKline, Teva Pharmaceutical, Eugia Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World DTIs for Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global DTIs for Injection Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global DTIs for Injection Market, Segmentation by Type:
    Argatroban
    Bivalirudin
    Other

Global DTIs for Injection Market, Segmentation by Application:
    Deep Vein Thrombosis
    Pulmonary Embolism
    Atrial Fibrillation
    Other

Companies Profiled:
    Mitsubishi Tanabe Pharma
    Pfizer
    Sandoz
    The Medicines Company
    Accord Healthcare
    Apotex
    Aurobindo Pharma
    GlaxoSmithKline
    Teva Pharmaceutical
    Eugia Pharma
    Dr.Reddy's Laboratories
    Yangtze River Pharmaceutical
    BrightGene
    Lunan Pharmaceutical
    CSPC Ouyi Pharmaceutical
    Beijing SL Pharmaceutical

Key Questions Answered:
1. How big is the global DTIs for Injection market?
2. What is the demand of the global DTIs for Injection market?
3. What is the year over year growth of the global DTIs for Injection market?
4. What is the production and production value of the global DTIs for Injection market?
5. Who are the key producers in the global DTIs for Injection market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 DTIs for Injection Introduction
    1.2 World DTIs for Injection Supply & Forecast
        1.2.1 World DTIs for Injection Production Value (2019 & 2023 & 2030)
        1.2.2 World DTIs for Injection Production (2019-2030)
        1.2.3 World DTIs for Injection Pricing Trends (2019-2030)
    1.3 World DTIs for Injection Production by Region (Based on Production Site)
        1.3.1 World DTIs for Injection Production Value by Region (2019-2030)
        1.3.2 World DTIs for Injection Production by Region (2019-2030)
        1.3.3 World DTIs for Injection Average Price by Region (2019-2030)
        1.3.4 North America DTIs for Injection Production (2019-2030)
        1.3.5 Europe DTIs for Injection Production (2019-2030)
        1.3.6 China DTIs for Injection Production (2019-2030)
        1.3.7 Japan DTIs for Injection Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 DTIs for Injection Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 DTIs for Injection Major Market Trends

2 Demand Summary
    2.1 World DTIs for Injection Demand (2019-2030)
    2.2 World DTIs for Injection Consumption by Region
        2.2.1 World DTIs for Injection Consumption by Region (2019-2024)
        2.2.2 World DTIs for Injection Consumption Forecast by Region (2025-2030)
    2.3 United States DTIs for Injection Consumption (2019-2030)
    2.4 China DTIs for Injection Consumption (2019-2030)
    2.5 Europe DTIs for Injection Consumption (2019-2030)
    2.6 Japan DTIs for Injection Consumption (2019-2030)
    2.7 South Korea DTIs for Injection Consumption (2019-2030)
    2.8 ASEAN DTIs for Injection Consumption (2019-2030)
    2.9 India DTIs for Injection Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World DTIs for Injection Production Value by Manufacturer (2019-2024)
    3.2 World DTIs for Injection Production by Manufacturer (2019-2024)
    3.3 World DTIs for Injection Average Price by Manufacturer (2019-2024)
    3.4 DTIs for Injection Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global DTIs for Injection Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for DTIs for Injection in 2023
        3.5.3 Global Concentration Ratios (CR8) for DTIs for Injection in 2023
    3.6 DTIs for Injection Market: Overall Company Footprint Analysis
        3.6.1 DTIs for Injection Market: Region Footprint
        3.6.2 DTIs for Injection Market: Company Product Type Footprint
        3.6.3 DTIs for Injection Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: DTIs for Injection Production Value Comparison
        4.1.1 United States VS China: DTIs for Injection Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: DTIs for Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: DTIs for Injection Production Comparison
        4.2.1 United States VS China: DTIs for Injection Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: DTIs for Injection Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: DTIs for Injection Consumption Comparison
        4.3.1 United States VS China: DTIs for Injection Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: DTIs for Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based DTIs for Injection Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based DTIs for Injection Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers DTIs for Injection Production Value (2019-2024)
        4.4.3 United States Based Manufacturers DTIs for Injection Production (2019-2024)
    4.5 China Based DTIs for Injection Manufacturers and Market Share
        4.5.1 China Based DTIs for Injection Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers DTIs for Injection Production Value (2019-2024)
        4.5.3 China Based Manufacturers DTIs for Injection Production (2019-2024)
    4.6 Rest of World Based DTIs for Injection Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based DTIs for Injection Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers DTIs for Injection Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers DTIs for Injection Production (2019-2024)

5 Market Analysis by Type
    5.1 World DTIs for Injection Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Argatroban
        5.2.2 Bivalirudin
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World DTIs for Injection Production by Type (2019-2030)
        5.3.2 World DTIs for Injection Production Value by Type (2019-2030)
        5.3.3 World DTIs for Injection Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World DTIs for Injection Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Deep Vein Thrombosis
        6.2.2 Pulmonary Embolism
        6.2.3 Atrial Fibrillation
        6.2.4 Other
    6.3 Market Segment by Application
        6.3.1 World DTIs for Injection Production by Application (2019-2030)
        6.3.2 World DTIs for Injection Production Value by Application (2019-2030)
        6.3.3 World DTIs for Injection Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Mitsubishi Tanabe Pharma
        7.1.1 Mitsubishi Tanabe Pharma Details
        7.1.2 Mitsubishi Tanabe Pharma Major Business
        7.1.3 Mitsubishi Tanabe Pharma DTIs for Injection Product and Services
        7.1.4 Mitsubishi Tanabe Pharma DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
        7.1.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer DTIs for Injection Product and Services
        7.2.4 Pfizer DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses
    7.3 Sandoz
        7.3.1 Sandoz Details
        7.3.2 Sandoz Major Business
        7.3.3 Sandoz DTIs for Injection Product and Services
        7.3.4 Sandoz DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Sandoz Recent Developments/Updates
        7.3.6 Sandoz Competitive Strengths & Weaknesses
    7.4 The Medicines Company
        7.4.1 The Medicines Company Details
        7.4.2 The Medicines Company Major Business
        7.4.3 The Medicines Company DTIs for Injection Product and Services
        7.4.4 The Medicines Company DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 The Medicines Company Recent Developments/Updates
        7.4.6 The Medicines Company Competitive Strengths & Weaknesses
    7.5 Accord Healthcare
        7.5.1 Accord Healthcare Details
        7.5.2 Accord Healthcare Major Business
        7.5.3 Accord Healthcare DTIs for Injection Product and Services
        7.5.4 Accord Healthcare DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Accord Healthcare Recent Developments/Updates
        7.5.6 Accord Healthcare Competitive Strengths & Weaknesses
    7.6 Apotex
        7.6.1 Apotex Details
        7.6.2 Apotex Major Business
        7.6.3 Apotex DTIs for Injection Product and Services
        7.6.4 Apotex DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Apotex Recent Developments/Updates
        7.6.6 Apotex Competitive Strengths & Weaknesses
    7.7 Aurobindo Pharma
        7.7.1 Aurobindo Pharma Details
        7.7.2 Aurobindo Pharma Major Business
        7.7.3 Aurobindo Pharma DTIs for Injection Product and Services
        7.7.4 Aurobindo Pharma DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Aurobindo Pharma Recent Developments/Updates
        7.7.6 Aurobindo Pharma Competitive Strengths & Weaknesses
    7.8 GlaxoSmithKline
        7.8.1 GlaxoSmithKline Details
        7.8.2 GlaxoSmithKline Major Business
        7.8.3 GlaxoSmithKline DTIs for Injection Product and Services
        7.8.4 GlaxoSmithKline DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 GlaxoSmithKline Recent Developments/Updates
        7.8.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.9 Teva Pharmaceutical
        7.9.1 Teva Pharmaceutical Details
        7.9.2 Teva Pharmaceutical Major Business
        7.9.3 Teva Pharmaceutical DTIs for Injection Product and Services
        7.9.4 Teva Pharmaceutical DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Teva Pharmaceutical Recent Developments/Updates
        7.9.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
    7.10 Eugia Pharma
        7.10.1 Eugia Pharma Details
        7.10.2 Eugia Pharma Major Business
        7.10.3 Eugia Pharma DTIs for Injection Product and Services
        7.10.4 Eugia Pharma DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Eugia Pharma Recent Developments/Updates
        7.10.6 Eugia Pharma Competitive Strengths & Weaknesses
    7.11 Dr.Reddy's Laboratories
        7.11.1 Dr.Reddy's Laboratories Details
        7.11.2 Dr.Reddy's Laboratories Major Business
        7.11.3 Dr.Reddy's Laboratories DTIs for Injection Product and Services
        7.11.4 Dr.Reddy's Laboratories DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Dr.Reddy's Laboratories Recent Developments/Updates
        7.11.6 Dr.Reddy's Laboratories Competitive Strengths & Weaknesses
    7.12 Yangtze River Pharmaceutical
        7.12.1 Yangtze River Pharmaceutical Details
        7.12.2 Yangtze River Pharmaceutical Major Business
        7.12.3 Yangtze River Pharmaceutical DTIs for Injection Product and Services
        7.12.4 Yangtze River Pharmaceutical DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Yangtze River Pharmaceutical Recent Developments/Updates
        7.12.6 Yangtze River Pharmaceutical Competitive Strengths & Weaknesses
    7.13 BrightGene
        7.13.1 BrightGene Details
        7.13.2 BrightGene Major Business
        7.13.3 BrightGene DTIs for Injection Product and Services
        7.13.4 BrightGene DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 BrightGene Recent Developments/Updates
        7.13.6 BrightGene Competitive Strengths & Weaknesses
    7.14 Lunan Pharmaceutical
        7.14.1 Lunan Pharmaceutical Details
        7.14.2 Lunan Pharmaceutical Major Business
        7.14.3 Lunan Pharmaceutical DTIs for Injection Product and Services
        7.14.4 Lunan Pharmaceutical DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Lunan Pharmaceutical Recent Developments/Updates
        7.14.6 Lunan Pharmaceutical Competitive Strengths & Weaknesses
    7.15 CSPC Ouyi Pharmaceutical
        7.15.1 CSPC Ouyi Pharmaceutical Details
        7.15.2 CSPC Ouyi Pharmaceutical Major Business
        7.15.3 CSPC Ouyi Pharmaceutical DTIs for Injection Product and Services
        7.15.4 CSPC Ouyi Pharmaceutical DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
        7.15.6 CSPC Ouyi Pharmaceutical Competitive Strengths & Weaknesses
    7.16 Beijing SL Pharmaceutical
        7.16.1 Beijing SL Pharmaceutical Details
        7.16.2 Beijing SL Pharmaceutical Major Business
        7.16.3 Beijing SL Pharmaceutical DTIs for Injection Product and Services
        7.16.4 Beijing SL Pharmaceutical DTIs for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.16.5 Beijing SL Pharmaceutical Recent Developments/Updates
        7.16.6 Beijing SL Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 DTIs for Injection Industry Chain
    8.2 DTIs for Injection Upstream Analysis
        8.2.1 DTIs for Injection Core Raw Materials
        8.2.2 Main Manufacturers of DTIs for Injection Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 DTIs for Injection Production Mode
    8.6 DTIs for Injection Procurement Model
    8.7 DTIs for Injection Industry Sales Model and Sales Channels
        8.7.1 DTIs for Injection Sales Model
        8.7.2 DTIs for Injection Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World DTIs for Injection Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World DTIs for Injection Production Value by Region (2019-2024) & (USD Million)
 Table 3. World DTIs for Injection Production Value by Region (2025-2030) & (USD Million)
 Table 4. World DTIs for Injection Production Value Market Share by Region (2019-2024)
 Table 5. World DTIs for Injection Production Value Market Share by Region (2025-2030)
 Table 6. World DTIs for Injection Production by Region (2019-2024) & (K Units)
 Table 7. World DTIs for Injection Production by Region (2025-2030) & (K Units)
 Table 8. World DTIs for Injection Production Market Share by Region (2019-2024)
 Table 9. World DTIs for Injection Production Market Share by Region (2025-2030)
 Table 10. World DTIs for Injection Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World DTIs for Injection Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. DTIs for Injection Major Market Trends
 Table 13. World DTIs for Injection Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World DTIs for Injection Consumption by Region (2019-2024) & (K Units)
 Table 15. World DTIs for Injection Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World DTIs for Injection Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key DTIs for Injection Producers in 2023
 Table 18. World DTIs for Injection Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key DTIs for Injection Producers in 2023
 Table 20. World DTIs for Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global DTIs for Injection Company Evaluation Quadrant
 Table 22. World DTIs for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and DTIs for Injection Production Site of Key Manufacturer
 Table 24. DTIs for Injection Market: Company Product Type Footprint
 Table 25. DTIs for Injection Market: Company Product Application Footprint
 Table 26. DTIs for Injection Competitive Factors
 Table 27. DTIs for Injection New Entrant and Capacity Expansion Plans
 Table 28. DTIs for Injection Mergers & Acquisitions Activity
 Table 29. United States VS China DTIs for Injection Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China DTIs for Injection Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China DTIs for Injection Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based DTIs for Injection Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers DTIs for Injection Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers DTIs for Injection Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers DTIs for Injection Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers DTIs for Injection Production Market Share (2019-2024)
 Table 37. China Based DTIs for Injection Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers DTIs for Injection Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers DTIs for Injection Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers DTIs for Injection Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers DTIs for Injection Production Market Share (2019-2024)
 Table 42. Rest of World Based DTIs for Injection Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers DTIs for Injection Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers DTIs for Injection Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers DTIs for Injection Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers DTIs for Injection Production Market Share (2019-2024)
 Table 47. World DTIs for Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World DTIs for Injection Production by Type (2019-2024) & (K Units)
 Table 49. World DTIs for Injection Production by Type (2025-2030) & (K Units)
 Table 50. World DTIs for Injection Production Value by Type (2019-2024) & (USD Million)
 Table 51. World DTIs for Injection Production Value by Type (2025-2030) & (USD Million)
 Table 52. World DTIs for Injection Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World DTIs for Injection Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World DTIs for Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World DTIs for Injection Production by Application (2019-2024) & (K Units)
 Table 56. World DTIs for Injection Production by Application (2025-2030) & (K Units)
 Table 57. World DTIs for Injection Production Value by Application (2019-2024) & (USD Million)
 Table 58. World DTIs for Injection Production Value by Application (2025-2030) & (USD Million)
 Table 59. World DTIs for Injection Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World DTIs for Injection Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
 Table 62. Mitsubishi Tanabe Pharma Major Business
 Table 63. Mitsubishi Tanabe Pharma DTIs for Injection Product and Services
 Table 64. Mitsubishi Tanabe Pharma DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Mitsubishi Tanabe Pharma Recent Developments/Updates
 Table 66. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
 Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
 Table 68. Pfizer Major Business
 Table 69. Pfizer DTIs for Injection Product and Services
 Table 70. Pfizer DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Pfizer Recent Developments/Updates
 Table 72. Pfizer Competitive Strengths & Weaknesses
 Table 73. Sandoz Basic Information, Manufacturing Base and Competitors
 Table 74. Sandoz Major Business
 Table 75. Sandoz DTIs for Injection Product and Services
 Table 76. Sandoz DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Sandoz Recent Developments/Updates
 Table 78. Sandoz Competitive Strengths & Weaknesses
 Table 79. The Medicines Company Basic Information, Manufacturing Base and Competitors
 Table 80. The Medicines Company Major Business
 Table 81. The Medicines Company DTIs for Injection Product and Services
 Table 82. The Medicines Company DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. The Medicines Company Recent Developments/Updates
 Table 84. The Medicines Company Competitive Strengths & Weaknesses
 Table 85. Accord Healthcare Basic Information, Manufacturing Base and Competitors
 Table 86. Accord Healthcare Major Business
 Table 87. Accord Healthcare DTIs for Injection Product and Services
 Table 88. Accord Healthcare DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Accord Healthcare Recent Developments/Updates
 Table 90. Accord Healthcare Competitive Strengths & Weaknesses
 Table 91. Apotex Basic Information, Manufacturing Base and Competitors
 Table 92. Apotex Major Business
 Table 93. Apotex DTIs for Injection Product and Services
 Table 94. Apotex DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Apotex Recent Developments/Updates
 Table 96. Apotex Competitive Strengths & Weaknesses
 Table 97. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
 Table 98. Aurobindo Pharma Major Business
 Table 99. Aurobindo Pharma DTIs for Injection Product and Services
 Table 100. Aurobindo Pharma DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Aurobindo Pharma Recent Developments/Updates
 Table 102. Aurobindo Pharma Competitive Strengths & Weaknesses
 Table 103. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
 Table 104. GlaxoSmithKline Major Business
 Table 105. GlaxoSmithKline DTIs for Injection Product and Services
 Table 106. GlaxoSmithKline DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. GlaxoSmithKline Recent Developments/Updates
 Table 108. GlaxoSmithKline Competitive Strengths & Weaknesses
 Table 109. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 110. Teva Pharmaceutical Major Business
 Table 111. Teva Pharmaceutical DTIs for Injection Product and Services
 Table 112. Teva Pharmaceutical DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Teva Pharmaceutical Recent Developments/Updates
 Table 114. Teva Pharmaceutical Competitive Strengths & Weaknesses
 Table 115. Eugia Pharma Basic Information, Manufacturing Base and Competitors
 Table 116. Eugia Pharma Major Business
 Table 117. Eugia Pharma DTIs for Injection Product and Services
 Table 118. Eugia Pharma DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Eugia Pharma Recent Developments/Updates
 Table 120. Eugia Pharma Competitive Strengths & Weaknesses
 Table 121. Dr.Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
 Table 122. Dr.Reddy's Laboratories Major Business
 Table 123. Dr.Reddy's Laboratories DTIs for Injection Product and Services
 Table 124. Dr.Reddy's Laboratories DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. Dr.Reddy's Laboratories Recent Developments/Updates
 Table 126. Dr.Reddy's Laboratories Competitive Strengths & Weaknesses
 Table 127. Yangtze River Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 128. Yangtze River Pharmaceutical Major Business
 Table 129. Yangtze River Pharmaceutical DTIs for Injection Product and Services
 Table 130. Yangtze River Pharmaceutical DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Yangtze River Pharmaceutical Recent Developments/Updates
 Table 132. Yangtze River Pharmaceutical Competitive Strengths & Weaknesses
 Table 133. BrightGene Basic Information, Manufacturing Base and Competitors
 Table 134. BrightGene Major Business
 Table 135. BrightGene DTIs for Injection Product and Services
 Table 136. BrightGene DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. BrightGene Recent Developments/Updates
 Table 138. BrightGene Competitive Strengths & Weaknesses
 Table 139. Lunan Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 140. Lunan Pharmaceutical Major Business
 Table 141. Lunan Pharmaceutical DTIs for Injection Product and Services
 Table 142. Lunan Pharmaceutical DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 143. Lunan Pharmaceutical Recent Developments/Updates
 Table 144. Lunan Pharmaceutical Competitive Strengths & Weaknesses
 Table 145. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 146. CSPC Ouyi Pharmaceutical Major Business
 Table 147. CSPC Ouyi Pharmaceutical DTIs for Injection Product and Services
 Table 148. CSPC Ouyi Pharmaceutical DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 149. CSPC Ouyi Pharmaceutical Recent Developments/Updates
 Table 150. CSPC Ouyi Pharmaceutical Competitive Strengths & Weaknesses
 Table 151. Beijing SL Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 152. Beijing SL Pharmaceutical Major Business
 Table 153. Beijing SL Pharmaceutical DTIs for Injection Product and Services
 Table 154. Beijing SL Pharmaceutical DTIs for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 155. Beijing SL Pharmaceutical Recent Developments/Updates
 Table 156. Beijing SL Pharmaceutical Competitive Strengths & Weaknesses
 Table 157. Global Key Players of DTIs for Injection Upstream (Raw Materials)
 Table 158. Global DTIs for Injection Typical Customers
 Table 159. DTIs for Injection Typical Distributors


List of Figures
 Figure 1. DTIs for Injection Picture
 Figure 2. World DTIs for Injection Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World DTIs for Injection Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World DTIs for Injection Production (2019-2030) & (K Units)
 Figure 5. World DTIs for Injection Average Price (2019-2030) & (US$/Unit)
 Figure 6. World DTIs for Injection Production Value Market Share by Region (2019-2030)
 Figure 7. World DTIs for Injection Production Market Share by Region (2019-2030)
 Figure 8. North America DTIs for Injection Production (2019-2030) & (K Units)
 Figure 9. Europe DTIs for Injection Production (2019-2030) & (K Units)
 Figure 10. China DTIs for Injection Production (2019-2030) & (K Units)
 Figure 11. Japan DTIs for Injection Production (2019-2030) & (K Units)
 Figure 12. DTIs for Injection Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World DTIs for Injection Consumption (2019-2030) & (K Units)
 Figure 15. World DTIs for Injection Consumption Market Share by Region (2019-2030)
 Figure 16. United States DTIs for Injection Consumption (2019-2030) & (K Units)
 Figure 17. China DTIs for Injection Consumption (2019-2030) & (K Units)
 Figure 18. Europe DTIs for Injection Consumption (2019-2030) & (K Units)
 Figure 19. Japan DTIs for Injection Consumption (2019-2030) & (K Units)
 Figure 20. South Korea DTIs for Injection Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN DTIs for Injection Consumption (2019-2030) & (K Units)
 Figure 22. India DTIs for Injection Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of DTIs for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for DTIs for Injection Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for DTIs for Injection Markets in 2023
 Figure 26. United States VS China: DTIs for Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: DTIs for Injection Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: DTIs for Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers DTIs for Injection Production Market Share 2023
 Figure 30. China Based Manufacturers DTIs for Injection Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers DTIs for Injection Production Market Share 2023
 Figure 32. World DTIs for Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World DTIs for Injection Production Value Market Share by Type in 2023
 Figure 34. Argatroban
 Figure 35. Bivalirudin
 Figure 36. Other
 Figure 37. World DTIs for Injection Production Market Share by Type (2019-2030)
 Figure 38. World DTIs for Injection Production Value Market Share by Type (2019-2030)
 Figure 39. World DTIs for Injection Average Price by Type (2019-2030) & (US$/Unit)
 Figure 40. World DTIs for Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 41. World DTIs for Injection Production Value Market Share by Application in 2023
 Figure 42. Deep Vein Thrombosis
 Figure 43. Pulmonary Embolism
 Figure 44. Atrial Fibrillation
 Figure 45. Other
 Figure 46. World DTIs for Injection Production Market Share by Application (2019-2030)
 Figure 47. World DTIs for Injection Production Value Market Share by Application (2019-2030)
 Figure 48. World DTIs for Injection Average Price by Application (2019-2030) & (US$/Unit)
 Figure 49. DTIs for Injection Industry Chain
 Figure 50. DTIs for Injection Procurement Model
 Figure 51. DTIs for Injection Sales Model
 Figure 52. DTIs for Injection Sales Channels, Direct Sales, and Distribution
 Figure 53. Methodology
 Figure 54. Research Process and Data Source

Companies Mentioned

Mitsubishi Tanabe Pharma
Pfizer
Sandoz
The Medicines Company
Accord Healthcare
Apotex
Aurobindo Pharma
GlaxoSmithKline
Teva Pharmaceutical
Eugia Pharma
Dr.Reddy's Laboratories
Yangtze River Pharmaceutical
BrightGene
Lunan Pharmaceutical
CSPC Ouyi Pharmaceutical
Beijing SL Pharmaceutical